➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
McKinsey
AstraZeneca
Colorcon
Express Scripts

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

Patent: 7,993,222

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,993,222
Title:Table-tennis bat(pen-holding type)
Abstract: The inventions published consist of `split-level step` between bat handle and contact section. This said step provides the newly inventions here the concept of critical holding points (called as C.H.P.)for the thumb, forefinger and any of other three fingers. These fingers can grip firmly onto the said step. This allows better swing of the bat, angle control, flexibility of bat manipulation and power. These C.H.P. also provides the proper gripping areas so that finger deformation problem is less likely to happen. In addition, it is less strainuous physically for the wrist and fingers, so the better power and performance of the players can be maintained longer naturally throughout the games. Besides, the invented C.H.P.concept can also be achieved (although it is less ideal compared to the `split level Step`) without adopting the `split-level step`(that is with the bend/joint angle between the split level equals zero degree) by having `raised-height-block` or raised step or `prolonged bottom handle` front and/or at the back of the bat (see Y & Z in FIGS. 3,4,5,6 & 7) so as to act as the C.H.P. as found in the split-leveled step (see X in FIGS. 2,4 & 7) (Note: to use drawing 7 for article publication purpose).
Inventor(s): Siow; Chong Peen (Singapore, SG)
Assignee:
Application Number:11/292,119
Patent Claims:see list of patent claims

Details for Patent 7,993,222

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial 2040-01-29 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
McKesson
Express Scripts
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.